Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer. // European Urology Open Science. – URL: https://www.sciencedirect.com/science/article/pii/S2666168326006671?dgcid=rss_sd_all
Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer. European Urology Open Science. https://www.sciencedirect.com/science/article/pii/S2666168326006671?dgcid=rss_sd_all
“Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer.” European Urology Open Science.
@article{article45598,
title = {Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer},
journal = {European Urology Open Science},
url = {https://www.sciencedirect.com/science/article/pii/S2666168326006671?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...